Drug Profile
Palauamine
Alternative Names: Palau'amineLatest Information Update: 17 Apr 2007
Price :
$50
*
At a glance
- Originator University of Hawaii
- Developer PharmaMar
- Class Antibacterials; Antifungals; Antineoplastics; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Oct 1999 Preclinical development for Cancer in Spain (Unknown route)
- 08 Sep 1998 No-Development-Reported for Cancer in Spain (Unknown route)
- 28 Aug 1996 Preclinical development for Cancer in Spain (Unknown route)